Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroids in Acute Urticaria in Emergency Department
2018-002308-15Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of prednisone in acute urticaria (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: 7-Days Urticaria Activity Score (UAS 7). Started Sep 2018; status: active.
02
Drugs
prednisone
03
Conditions
acute urticaria
Beyond the preview
Go deeper on 2018-002308-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002308-15.